Literature DB >> 19424008

Mesenchymal stem cells in the induction of transplantation tolerance.

Amelia Bartholomew1, David Polchert, Erzsebet Szilagyi, G W Douglas, Norma Kenyon.   

Abstract

Mesenchymal stem cells directly suppress ongoing immune responses. Through production of toleragenic cytokines, inhibition of lymphocyte proliferation, delivery of reparative and protective signals after reperfusion injury, and facilitation of hematopoietic chimerism, these cells demonstrate a wide-ranging potential for the development of multifaceted toleragenic strategies after transplantation.

Mesh：

Year:  2009        PMID： 19424008     DOI： 10.1097/TP.0b013e3181a287e6

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


  11 in total

Review 1.  The immunomodulatory properties of mesenchymal stem cells: implications for surgical disease.

Authors:  Brent R Weil; Mariuxi C Manukyan; Jeremy L Herrmann; Aaron M Abarbanell; Jeffrey A Poynter; Yue Wang; Daniel R Meldrum
Journal:  J Surg Res       Date:  2010-08-06       Impact factor: 2.192

Review 2.  Tissue engineering tools for modulation of the immune response.

Authors:  Ryan M Boehler; John G Graham; Lonnie D Shea
Journal:  Biotechniques       Date:  2011-10       Impact factor: 1.993

Review 3.  Potential benefits of allogeneic bone marrow mesenchymal stem cells for wound healing.

Authors:  Alexander R Badiavas; Evangelos V Badiavas
Journal:  Expert Opin Biol Ther       Date:  2011-08-20       Impact factor: 4.388

Review 4.  Stem cell-based strategies for the treatment of type 1 diabetes mellitus.

Authors:  Yujie Wen; Bo Chen; Suzanne T Ildstad
Journal:  Expert Opin Biol Ther       Date:  2010-11-29       Impact factor: 4.388

5.  An immunoprotective privilege of corneal epithelial stem cells against Th17 inflammatory stress by producing glial cell-derived neurotrophic factor.

Authors:  Fang Bian; Hong Qi; Ping Ma; Lili Zhang; Kyung-Chul Yoon; Stephen C Pflugfelder; De-Quan Li
Journal:  Stem Cells       Date:  2010-12       Impact factor: 6.277

Review 6.  Unexpected roles for bone marrow stromal cells (or MSCs): a real promise for cellular, but not replacement, therapy.

Authors:  E Mezey; B Mayer; K Németh
Journal:  Oral Dis       Date:  2009-07-27       Impact factor: 3.511

Review 7.  Biomarkers of immune tolerance in kidney transplantation: an overview.

Authors:  Wee-Song Yeo; Qin Xiang Ng
Journal:  Pediatr Nephrol       Date:  2021-03-12       Impact factor: 3.714

8.  Extended survival versus accelerated rejection of nonhuman primate islet allografts: Effect of mesenchymal stem cell source and timing.

Authors:  Norma S Kenyon; Melissa A Willman; Dongmei Han; Rachel S Leeman; Alex Rabassa; Waldo L Diaz; James C Geary; Ena Poumian-Ruiz; Anthony J Griswold; Derek J Van Booven; Ryan Thompson; Philip Ordoukhanian; Steven R Head; Norman M Kenyon; Kenton G McHenry; Daniel R Salomon; Amelia M Bartholomew; Dora M Berman
Journal:  Am J Transplant       Date:  2021-07-02       Impact factor: 8.086

9.  Mesenchymal stem cells enhance allogeneic islet engraftment in nonhuman primates.

Authors:  Dora M Berman; Melissa A Willman; Dongmei Han; Gary Kleiner; Norman M Kenyon; Over Cabrera; Julie A Karl; Roger W Wiseman; David H O'Connor; Amelia M Bartholomew; Norma S Kenyon
Journal:  Diabetes       Date:  2010-07-09       Impact factor: 9.461

10.  Efficient co-expression of bicistronic proteins in mesenchymal stem cells by development and optimization of a multifunctional plasmid.

Authors:  Christopher D Krause; Lara S Izotova; Gwangwen Ren; Zeng-Rong Yuan; Yufang Shi; Chiann-Chyi Chen; Yacov Ron; Sidney Pestka
Journal:  Stem Cell Res Ther       Date:  2011-03-14       Impact factor: 6.832
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.